Politics Patients sue GLP-1 makers over sudden loss of visionBy channel1la.comSeptember 22, 20260 Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.
Politics Which GLP-1 works best? New meta-study puts them head-to-headBy channel1la.comJune 20, 20260 The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold…
